• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Death (after percutaneous coronary intervention) is no longer what it used to be.

作者信息

Steg Philippe Gabriel, Cheong Adrian Piers

机构信息

From Université Paris-Diderot, DHU FIRE, Paris, France (P.G.S.); Hôpital Bichat, Paris, France (P.G.S., A.P.C.); INSERM U-1148, Paris, France (P.G.S.); NHLI, Imperial College, ICMS, Royal Brompton Hospital, London, UK (P.G.S.); Prince of Wales Hospital, Hong Kong, China (A.P.C.); and The Chinese University of Hong Kong, Hong Kong, China (A.P.C.).

出版信息

Circulation. 2014 Mar 25;129(12):1267-9. doi: 10.1161/CIRCULATIONAHA.114.008492. Epub 2014 Feb 10.

DOI:10.1161/CIRCULATIONAHA.114.008492
PMID:24515992
Abstract
摘要

相似文献

1
Death (after percutaneous coronary intervention) is no longer what it used to be.（经皮冠状动脉介入治疗后的）死亡已今非昔比。
Circulation. 2014 Mar 25;129(12):1267-9. doi: 10.1161/CIRCULATIONAHA.114.008492. Epub 2014 Feb 10.
2
Trends in cause of death after percutaneous coronary intervention.经皮冠状动脉介入治疗后死亡原因的趋势。
Circulation. 2014 Mar 25;129(12):1286-94. doi: 10.1161/CIRCULATIONAHA.113.006518. Epub 2014 Feb 10.
3
Interventional cardiology: Causes of death after PCI.
Nat Rev Cardiol. 2014 Apr;11(4):186. doi: 10.1038/nrcardio.2014.20. Epub 2014 Feb 25.
4
Percutaneous coronary intervention versus medical therapy for stable coronary artery disease: meta-regression analysis of mortality and morbidity against stent use.
Int J Cardiol. 2011 Jul 1;150(1):90-2. doi: 10.1016/j.ijcard.2011.03.034. Epub 2011 Apr 17.
5
Does percutaneous coronary intervention compromise the outcome of subsequent coronary artery bypass grafting?
JACC Cardiovasc Interv. 2009 Aug;2(8):765-6. doi: 10.1016/j.jcin.2009.06.005.
6
Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention.连续 4880 例行经皮冠状动脉介入治疗患者队列中的肥胖悖论。
Eur Heart J. 2010 Jan;31(2):222-6. doi: 10.1093/eurheartj/ehp317. Epub 2009 Aug 17.
7
Impact of right coronary artery disease on mortality in patients undergoing percutaneous coronary intervention of unprotected left main coronary artery disease.右冠状动脉疾病对非保护左主干冠状动脉疾病经皮冠状动脉介入治疗患者死亡率的影响。
EuroIntervention. 2010 Sep;6(4):454-60. doi: 10.4244/EIJ30V6I4A77.
8
Left ventricular support systems for high-risk percutaneous coronary interventions: how can we improve outcomes for rare procedures?
Circulation. 2013 Jan 15;127(2):162-4. doi: 10.1161/CIRCULATIONAHA.112.152785. Epub 2012 Dec 6.
9
Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.稳定多血管冠状动脉疾病患者随机接受手术、血管成形术或药物治疗的 10 年结果：Medicine, Angioplasty, or Surgery Study II 试验中年龄的影响。
J Thorac Cardiovasc Surg. 2013 Nov;146(5):1105-12. doi: 10.1016/j.jtcvs.2012.08.015. Epub 2012 Aug 31.
10
One year clinical outcomes in patients with chronic kidney disease treated by percutaneous coronary intervention with drug-eluting stent.经皮冠状动脉介入术联合药物洗脱支架治疗慢性肾脏病患者的一年临床结局
Int J Cardiol. 2011 Mar 3;147(2):307. doi: 10.1016/j.ijcard.2010.12.061. Epub 2011 Jan 6.

引用本文的文献

1
Risk of Cancer After Diagnosis of Cardiovascular Disease.心血管疾病诊断后的癌症风险。
JACC CardioOncol. 2023 Apr 11;5(4):431-440. doi: 10.1016/j.jaccao.2023.01.010. eCollection 2023 Aug.
2
Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease.逆向心血管肿瘤学：心血管疾病患者的癌症发展
J Am Heart Assoc. 2020 Jan 21;9(2):e013754. doi: 10.1161/JAHA.119.013754.
3
Incidence of cancers in patients with atherosclerotic cardiovascular diseases.
Int J Cardiol Heart Vasc. 2017 Sep 14;17:11-16. doi: 10.1016/j.ijcha.2017.08.004. eCollection 2017 Dec.
4
Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.延长双联抗血小板治疗时间与死亡率：系统评价和荟萃分析。
Lancet. 2015 Feb 28;385(9970):792-8. doi: 10.1016/S0140-6736(14)62052-3. Epub 2014 Nov 16.